Age-related β-adrenergic receptor-mediated vasorelaxation is changed by altering G protein receptor kinase 2 expression

Vascular Pharmacology

Volumn 55, Issue 5-6, 2011, Pages 178-188

  Schutzer, William E ^a,b   Xue, Hong ^a   Reed, John ^a   Oyama, Terry ^a   Beard, Douglas R ^a   Anderson, Sharon ^a,b   Mader, Scott L ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adenovirus; Adrenergic beta; Aging; Fischer 344; G protein receptor kinase (GRK); Vasorelaxation

Indexed keywords

BETA ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CAROTID ARTERY; EX VIVO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGING; ANIMALS; AORTA; CAROTID ARTERIES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; G-PROTEIN-COUPLED RECEPTOR KINASE 2; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED F344; RECEPTORS, ADRENERGIC, BETA; RECOMBINANT PROTEINS; UP-REGULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 84866549413     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.09.001     Document Type: Article

References (53)

1. Baloglu E., Kiziltepe O., Gurdal H. The role of Gi proteins in reduced vasorelaxation response to β-adrenoceptor agonists in rat aorta during maturation. Eur. J. Pharmacol. 2007, 564:167-173.
2. Brinks H., Koch W. βARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease. J. Cardiovasc. Transl. Res. 2010, 3:499-506.
3. Bukowski R., McCarron D. Altered aortic reactivity and lowered blood pressure associated with high calcium intake. Am. J. Physiol. 1986, 251:H976-H983.
4. Butcher A.J., Prihandoko R., Kong K.C., McWilliams P., Edwards J.M., Bottrill A., Mistry S., Tobin A.B. Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code. J. Biol. Chem. 2011, 286:11506-11518.
5. Carman C.V., Lisanti M.P., Benovic J.L. Regulation of G-protein receptor kinases by caveolin. J. Biol. Chem. 1999, 274:8858-8864.
6. Chapman J., Schutzer W.E., Watts V.J., Mader S.L. Impaired cholera toxin relaxation with age in rat aorta. J. Gerontol.: Biol. Sci. 1999, 54:B154-B159.
7. Charlton S.J. Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. Br. J. Pharmacol. 2009, 158:165-168.
8. Chin J.H., Hiremath A.N., Hoffman B.B. cAMP signaling mechanisms with aging in rats. Mech. Ageing Dev. 1996, 86:11-26.
9. Clark R.B., Rich T.C. Probing the roles of protein kinases in G-protein-coupled receptor desensitization. Mol. Pharmacol. 2003, 64:1015-1017.
10. Cohn H.I., Harris D.M., Pesant S., Pfeiffer M., Zhou R.H., Koch W.J., Dorn G.W., Eckhart A.D. Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances α1D-adrenergic receptor constriction. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1695-H1704.
11. 2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997, 390:88-91.
12. Deisher T.A., Mankani S., Hoffman B.B. Role of cyclic AMP-dependent protein kinase in the diminished β-adrenergic responsiveness of vascular smooth muscle with increasing age. J. Pharmacol. Exp. Ther. 1989, 249:812-819.
13. Drazner M.H., Peppel K.C., Dyer S., Grant A.O., Koch W.J., Lefkowitz R.J. Potentiation of β-adrenergic signaling by adenoviral-mediated gene tranfer in adult rabbit ventricular myocytes. J. Clin. Investig. 1997, 99:288-296.
14. Eckhart A.D., Ozaki T., Tevaearai H., Rockman H.A., Koch W.J. Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates β-adrenergic receptor signaling and increases resting blood pressure. Mol. Pharmacol. 2002, 61:749-758.
15. Felder R.A., Sanada H., Xu J., Yu P.-Y., Wang Z., Watanabe H., Asico L.D., Wang W., Zheng S., Yamaguchi I., Williams S.M., Gainer J., Brown N.J., Hazen-Martin D., Wong L.-J.C., Robillard J.E., Carey R.M., Eisner G.M., Jose P.A. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3872-3877.
16. Feldman R.D., Gros R. Defective vasodilatory mechanisms in hypertension: a G-protein-coupled receptor perspective. Curr. Opin. Nephrol. Hypertens. 2006, 15:135-140.
17. 2-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr. Biol. 2000, 10:409-412.
18. 2-adrenergic receptors in large arteries. J. Mol. Cell. Cardiol. 1998, 30:1037-1045.
19. Gurdal H., Friedman E., Johnson M. β-adrenoceptor-Gαs coupling decreases with age in rat aorta. Mol. Pharmacol. 1995, 47:772-778.
20. Hariri R.J., Hajjar D.P., Coletti D., Alonso D.R., Weksler M.E., Rabellino E. Aging and atheriosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. Am. J. Pathol. 1988, 131:132-136.
21. Izzo R., Cipolletta E., Ciccarelli M., Campanile A., Santulli G., Palumbo G., Vasta A., Formisano S., Trimarco B., Iaccarino G. Enhanced GRK2 expression and desensitization of βAR vasodilatation in hypertensive patients. Clin. Transl. Sci. 2008, 1:215-220.
22. 2-adrenergic receptor function, response, and regulation. J. Allergy Clin. Immunol. 2006, 117:18-24.
23. Johnson M.D., Zhou Y., Friedman E., Roberts J. Expression of G-protein-α subunits in the aging cardiovascular system. J. Gerontol.: Biol. Sci. 1995, 50A:B14-B19.
24. Keys J.R., Zhou R.H., Harris D.M., Druckman C.A., Eckhart A.D. Vascular smooth muscle overexpression of G protein-coupled receptor kinase 5 elevates blood pressure, which segregates with sex and is dependent on Gi-mediated signaling. Circulation 2005, 112:1145-1153.
25. Koch W.J., Hawes B.E., Inglese J., Luttrell L.M., Lefkowitz R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates Gβγ-mediated signaling. J. Biol. Chem. 1994, 269:6193-6197.
26. Koch W.J., Rockman H.A., Samama P., Hamilton R., Bond R.A., Milano C.A., Lefkowitz R.J. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 1995, 268:1350-1353.
27. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by β-arrestins. Science 2005, 308:512-517.
28. Lefkowitz R.J., Pitcher J., Krueger K.M., Daaka Y. Mechanisms of β-adrenergic receptor desensitization and resensitization. Adv. Pharmacol. 1998, 42:416-420.
29. Leosco D., Iaccarino G., Cipolletta E., De Santis D., Pisani E., Trimarco V., Ferrara N., Abete P., Sorriento D., Rengo F., Trimarco B. Exercise restores β-adrenergic vasorelaxation in aged rat carotid arteries. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H369-H374.
30. Lymperopoulos A., Rengo G., Zincarelli C., Soltys S., Koch W.J. Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity. Mol. Ther. 2008, 16:302-307.
31. Mader S.L., Alley P.A. Age-related changes in adenylyl cyclase activity in rat aorta membranes. Mech. Ageing Dev. 1998, 101:111-118.
32. Mader S.L., Downing C.L., Amos-Landgraf J., Swebjka P. Age-related changes in G proteins in rat aorta. J. Gerontol.: Biol. Sci. 1996, 51:B111-B116.
33. Marin J. Age-related changes in vascular responses: a review. Mech. Ageing Dev. 1995, 79:71-114.
34. Melvin D.C. Cardiovascular physiology; changes with aging. Am. J. Geriatr. Cardiol. 2003, 12:9-13.
35. Nobles K.N., Xiao K., Ahn S., Shukla A.K., Lam C.M., Rajagopal S., Strachan R.T., Huang T.-Y., Bressler E.A., Hara M.R., Shenoy S.K., Gygi S.P., Lefkowitz R.J. Distinct phosphorylation sites on the β2-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin. Sci. Signal. 2011, 4:ra51.
36. Pan H.Y., Hoffman B.B., Pershe R.A., Blaschke T.F. Decline in β-adrenergic receptor-mediated vascular relaxation with aging in man. J. Pharmacol. Exp. Ther. 1986, 239:802-807.
37. Pitcher J.A., Freedman N.J., Lefkowitz R.J. G protein-coupled receptor kinases. Annu. Rev. Biochem. 1998, 67:653-692.
38. Rodriguez M.M., Ron D., Touhara K., Chen C.H., Mochly-Rosen D. RACK1, a protein kinase C anchoring protein, coordinates the binding of activated protein kinase C and select pleckstrin homology domains in vitro. Biochemistry 1999, 38:13787-13794.
39. Schutzer W.E., Mader S.L. Age-related changes in adrenergic signaling: clinical and mechanistic implications. Ageing Res. Rev. 2003, 2:169-190.
40. Schutzer W.E., Watts V.J., Chapman J., Cumbay M.G., Neve K.A., Neve R.L., Mader S.L. Viral-mediated gene delivery of constitutively activated Gαs alters vasoreactivity. Clin. Exp. Pharmacol. Physiol. 2000, 27:9-13.
41. Schutzer W.E., Xue H., Reed J.R., Roullet J.-B., Anderson S., Mader S.L. Angiotensin II enhances β-adrenergic receptor-mediated vasorelaxation in aorta from young but not old rats. Am. J. Physiol. 2000, 279:H2807-H2814.
42. Schutzer W.E., Reed J.F., Bliziotes M., Mader S.L. Upregulation of G protein-linked receptor kinases with advancing age in rat aorta. Am. J. Physiol. 2001, 280:R897-R903.
43. Schutzer W.E., Reed J.F., Mader S.L. Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2457-H2464.
44. 2-adrenergic receptor desensitization is not mediated by the receptor coupling to Gαi proteins. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:899-906.
45. Schwencke C., Okumura S., Yamamoto M., Geng Y.-J., Ishikawa Y. Colocalization of β-adrenergic receptors and caveolin within the plasma membrane. J. Cell. Biochem. 1999, 75:64-72.
46. Seibold A., Williams B., Huang Z.-F., Friedman J., Moore R.H., Knoll B.J., Clark R.B. Localization of the sites mediating desensitization of the β2-Adrenergic receptor by the GRK pathway. Mol. Pharmacol. 2000, 58:1162-1173.
47. Somlyo A.P., Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature 1994, 372:231-236.
48. 2-adrenergic receptor using phosphoserine-specific antibodies. Mol. Pharmacol. 2004, 65:196-206.
49. Tsujimoto G., Lee C.H., Hoffman B.B. Age-related decrease in β-adrenergic receptor-mediated vascular smooth muscle relaxation. J. Pharmacol. Exp. Ther. 1986, 239:411-415.
50. 2-adrenergic receptors in the plasma membrane of cardiomyocyte-like H9c2 cells is mediated by selective interactions with PDZ domain and A-kinase anchoring proteins but not caveolae. Mol. Biol. Cell 2011, 22:2970-2982.
51. van der Zypp A., Kang K.B., Majewski H. Age-related involvement of the endothelium in beta-adrenoceptor-mediated relaxation of rat aorta. Eur. J. Pharmacol. 2000, 397:129-138.
52. Wang Y., Thorne S., Hannock J., Francis J., Au T., Reid T., Lemoine N., Kirn D., Hallden G. A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses. Clin. Cancer Res. 2005, 11:351-360.
53. 2-adrenergic receptor to G(s) and G(i) proteins. Sci. STKE 2001, RE15.